Cargando…
Antisense Oligonucleotide Technologies to Combat Obesity and Fatty Liver Disease
Synthetic oligonucleotide technologies are DNA or RNA based molecular compounds that are utilized to disrupt gene transcription or translation in target tissues or cells. Optimally, oligonucleotides are 10–30 base pairs in length, and mediate target gene suppression through directed sequence homolog...
Autores principales: | Keating, Michael F., Drew, Brian G., Calkin, Anna C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918623/ https://www.ncbi.nlm.nih.gov/pubmed/35295579 http://dx.doi.org/10.3389/fphys.2022.839471 |
Ejemplares similares
-
A mechanistic pharmacokinetic model for intrathecal administration of antisense oligonucleotides
por: Linninger, Andreas A., et al.
Publicado: (2023) -
Adipose-Derived Extracellular Vesicles: Systemic Messengers and Metabolic Regulators in Health and Disease
por: Bond, Simon T., et al.
Publicado: (2022) -
The Antioxidant Moiety of MitoQ Imparts Minimal Metabolic Effects in Adipose Tissue of High Fat Fed Mice
por: Bond, Simon T., et al.
Publicado: (2019) -
Antisense oligonucleotide is a promising intervention for liver diseases
por: Lu, Kailing, et al.
Publicado: (2022) -
Advances of Antisense Oligonucleotide Technology in the Treatment of Hereditary Neurodegenerative Diseases
por: Lin, Mengsi, et al.
Publicado: (2021)